177 related articles for article (PubMed ID: 26678599)
1. Dose-volume relationships for moderate or severe neck muscle atrophy after intensity-modulated radiotherapy in patients with nasopharyngeal carcinoma.
Zhang LL; Wang XJ; Zhou GQ; Tang LL; Lin AH; Ma J; Sun Y
Sci Rep; 2015 Dec; 5():18415. PubMed ID: 26678599
[TBL] [Abstract][Full Text] [Related]
2. The Evolution of and Risk Factors for Neck Muscle Atrophy and Weakness in Nasopharyngeal Carcinoma Treated With Intensity-Modulated Radiotherapy: A Retrospective Study in an Endemic Area.
Zhang LL; Mao YP; Zhou GQ; Tang LL; Qi ZY; Lin L; Yao JJ; Ma J; Lin AH; Sun Y
Medicine (Baltimore); 2015 Aug; 94(31):e1294. PubMed ID: 26252307
[TBL] [Abstract][Full Text] [Related]
3. Patient- and treatment-related risk factors associated with neck muscle spasm in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy.
Zhang LL; Zhou GQ; Qi ZY; He XJ; Li JX; Tang LL; Mao YP; Lin AH; Ma J; Sun Y
BMC Cancer; 2017 Nov; 17(1):788. PubMed ID: 29169335
[TBL] [Abstract][Full Text] [Related]
4. A retrospective dosimetry study of intensity-modulated radiotherapy for nasopharyngeal carcinoma: radiation-induced brainstem injury and dose-volume analysis.
Yao CY; Zhou GR; Wang LJ; Xu JH; Ye JJ; Zhang LF; He X; Chen ZZ; Huang SF
Radiat Oncol; 2018 Oct; 13(1):194. PubMed ID: 30285884
[TBL] [Abstract][Full Text] [Related]
5. Radiation-induced temporal lobe injury after intensity modulated radiotherapy in nasopharyngeal carcinoma patients: a dose-volume-outcome analysis.
Sun Y; Zhou GQ; Qi ZY; Zhang L; Huang SM; Liu LZ; Li L; Lin AH; Ma J
BMC Cancer; 2013 Aug; 13():397. PubMed ID: 23978128
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric analysis of radiation-induced brainstem necrosis for nasopharyngeal carcinoma treated with IMRT.
Fan X; Huang Y; Xu P; Min Y; Li J; Feng M; Xu G; Lang J
BMC Cancer; 2022 Feb; 22(1):178. PubMed ID: 35177030
[TBL] [Abstract][Full Text] [Related]
7. Evolution and Dosimetric Analysis of Magnetic Resonance Imaging-Detected Brain Stem Injury After Intensity Modulated Radiation Therapy in Nasopharyngeal Carcinoma.
Huang XD; Li YC; Chen FP; Zheng WH; Zhou GQ; Lin L; Hu J; He WJ; Zhang LL; Kou J; Ma J; Zhang WD; Qi ZY; Sun Y
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):124-131. PubMed ID: 31075310
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric parameters associated with conductive or sensorineural hearing loss 5 years after intensity-modulated radiation therapy in nasopharyngeal carcinoma.
Zhu W; Chen F; Li J; Wang W; Zhang H; Yang G; Zou L; Zhu Y; Yuan W; Ding H; Song X; Wang S
Acta Otolaryngol; 2019 Mar; 139(3):263-268. PubMed ID: 30870056
[TBL] [Abstract][Full Text] [Related]
9. LASSO-based NTCP model for radiation-induced temporal lobe injury developing after intensity-modulated radiotherapy of nasopharyngeal carcinoma.
Kong C; Zhu XZ; Lee TF; Feng PB; Xu JH; Qian PD; Zhang LF; He X; Huang SF; Zhang YQ
Sci Rep; 2016 May; 6():26378. PubMed ID: 27210263
[TBL] [Abstract][Full Text] [Related]
10.
Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study.
Huang J; Kong FF; Oei RW; Zhai RP; Hu CS; Ying HM
Radiat Oncol; 2019 Feb; 14(1):31. PubMed ID: 30736809
[TBL] [Abstract][Full Text] [Related]
12. Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma.
Yao JJ; Zhou GQ; Lin L; Zhang WJ; Peng YL; Chen L; Tang LL; Mao YP; Ma J; Sun Y
Sci Rep; 2015 Sep; 5():13525. PubMed ID: 26323586
[TBL] [Abstract][Full Text] [Related]
13. Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose-toxicity relationship.
Chow JCH; Cheung KM; Au KH; Zee BCY; Lee J; Ngan RKC; Lee AWM; Yiu HHY; Li KWS; Leung AKC; Chan JCH; Lee FKH; Wong KH
Radiother Oncol; 2019 Sep; 138():93-98. PubMed ID: 31252300
[TBL] [Abstract][Full Text] [Related]
14. Temporal lobe injury patterns following intensity modulated radiotherapy in a large cohort of nasopharyngeal carcinoma patients.
Lu L; Sheng Y; Zhang G; Li Y; OuYang PY; Ge Y; Xie T; Chang H; Deng X; Wu JQ
Oral Oncol; 2018 Oct; 85():8-14. PubMed ID: 30220323
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
16. Clinical and dosimetric characteristics of temporal lobe injury following intensity modulated radiotherapy of nasopharyngeal carcinoma.
Su SF; Huang Y; Xiao WW; Huang SM; Han F; Xie CM; Lu TX
Radiother Oncol; 2012 Sep; 104(3):312-6. PubMed ID: 22857858
[TBL] [Abstract][Full Text] [Related]
17. Effect of dosimetric factors on occurrence and volume of temporal lobe necrosis following intensity modulated radiation therapy for nasopharyngeal carcinoma: a case-control study.
Zhou X; Ou X; Xu T; Wang X; Shen C; Ding J; Hu C
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):261-9. PubMed ID: 25066214
[TBL] [Abstract][Full Text] [Related]
18. Radiation-induced nasopharyngeal ulcers after intensity modulated radiotherapy in primary nasopharyngeal carcinoma patients: A dose-volume-outcome analysis.
Li Y; Xu T; Qian W; Lu X; Hu C
Oral Oncol; 2018 Sep; 84():1-6. PubMed ID: 30115466
[TBL] [Abstract][Full Text] [Related]
19. Hypothalamic-pituitary-thyroid dysfunction induced by intensity-modulated radiotherapy (IMRT) for adult patients with nasopharyngeal carcinoma.
Huang S; Wang X; Hu C; Ying H
Med Oncol; 2013 Dec; 30(4):710. PubMed ID: 23999842
[TBL] [Abstract][Full Text] [Related]
20. PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.
Liu F; Xi XP; Wang H; Han YQ; Xiao F; Hu Y; He Q; Zhang L; Xiao Q; Liu L; Luo L; Li Y; Mo Y; Ma HZ
Radiat Oncol; 2017 Jan; 12(1):15. PubMed ID: 28587681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
